These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26035274)

  • 21. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?
    Bernardo ME; Pagliara D; Locatelli F
    Bone Marrow Transplant; 2012 Feb; 47(2):164-71. PubMed ID: 21478914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells.
    Lei J; Hui D; Huang W; Liao Y; Yang L; Liu L; Zhang Q; Qi G; Song W; Zhang Y; Xiang AP; Zhou Q
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2431-43. PubMed ID: 23911306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
    Millard SM; Fisk NM
    Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of mesenchymal stromal cells from extraembryonic tissues and their characteristics.
    Veryasov VN; Savilova AM; Buyanovskaya OA; Chulkina MM; Pavlovich SV; Sukhikh GT
    Bull Exp Biol Med; 2014 May; 157(1):119-24. PubMed ID: 24909727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological basis of stem cell therapy in liver diseases.
    Cui L; Shi Y; Han Y; Fan D
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1185-96. PubMed ID: 24964800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells for the treatment of heart disease.
    Yamahara K; Nagaya N
    Regen Med; 2007 Mar; 2(2):107-9. PubMed ID: 17465743
    [No Abstract]   [Full Text] [Related]  

  • 27. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism.
    Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.
    Motaln H; Gruden K; Hren M; Schichor C; Primon M; Rotter A; Lah TT
    Cell Transplant; 2012; 21(7):1529-45. PubMed ID: 22554389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cell based therapy for osteo-diseases.
    Ghasroldasht MM; Irfan-Maqsood M; Matin MM; Bidkhori HR; Naderi-Meshkin H; Moradi A; Bahrami AR
    Cell Biol Int; 2014 Oct; 38(10):1081-5. PubMed ID: 24797260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations.
    Wang J; Liao L; Wang S; Tan J
    Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal Stem Cells as a Source of Repair Cytokines: Mesenchymal Stem Cells as the Conductor.
    Stoddart MJ
    J Am Acad Orthop Surg; 2015 Jul; 23(7):452-3. PubMed ID: 26040952
    [No Abstract]   [Full Text] [Related]  

  • 32. Encapsulated mesenchymal stem cells for in vivo immunomodulation.
    Zanotti L; Sarukhan A; Dander E; Castor M; Cibella J; Soldani C; Trovato AE; Ploia C; Luca G; Calvitti M; Mancuso F; Arato I; Golemac M; Jonjic N; Biondi A; Calafiore R; Locati M; D'Amico G; Viola A
    Leukemia; 2013 Feb; 27(2):500-3. PubMed ID: 22878604
    [No Abstract]   [Full Text] [Related]  

  • 33. Dissecting paracrine effectors for mesenchymal stem cells.
    Bruno S; Collino F; Tetta C; Camussi G
    Adv Biochem Eng Biotechnol; 2013; 129():137-52. PubMed ID: 22968371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cells and transplant tolerance.
    Vanikar AV; Trivedi HL; Kumar A; Gopal SC; Kute VB
    Nephrology (Carlton); 2014 Jul; 19(7):369-74. PubMed ID: 24698403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stromal cells: are they ready for prime time?
    Kamani NR
    Transfusion; 2016 Apr; 56(4):1S. PubMed ID: 27079317
    [No Abstract]   [Full Text] [Related]  

  • 36. Support of hepatic regeneration by trophic factors from liver-derived mesenchymal stromal/stem cells.
    Fouraschen SM; Hall SR; de Jonge J; van der Laan LJ
    Methods Mol Biol; 2014; 1213():89-104. PubMed ID: 25173377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics.
    McIntosh KR; Frazier T; Rowan BG; Gimble JM
    Expert Rev Clin Immunol; 2013 Feb; 9(2):175-84. PubMed ID: 23390948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical study using adipose-derived mesenchymal-like stem cells in acute myocardial infarction and heart failure.
    Panfilov IA; de Jong R; Takashima S; Duckers HJ
    Methods Mol Biol; 2013; 1036():207-12. PubMed ID: 23807797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of mesenchymal stem cells as treatment for graft-versus-host disease: current knowledge and controversies.
    Ortín M; Sierra J
    Immunotherapy; 2011 Jun; 3(6):701-4. PubMed ID: 21668303
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation, characterization, differentiation, and application of adipose-derived stem cells.
    Kuhbier JW; Weyand B; Radtke C; Vogt PM; Kasper C; Reimers K
    Adv Biochem Eng Biotechnol; 2010; 123():55-105. PubMed ID: 20091288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.